Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck

Radiotherapy and Oncology

Volumn 50, Issue 1, 1999, Pages 47-55

  Stausbøl Grøn, Birgitte ^a   Overgaard, Jens ^a,b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Courtenay Mills assay; Fibroblasts; Head and neck cancer; Predictive assays; Radiotherapy; SF2; Tumour cell radiosensitivity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; COLORING AGENTS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LINEAR MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 17144449691     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00129-7     Document Type: Article

References (43)

1. Sobin LH. Head and neck tumours. In: Hermanek P, Sobin LH, editors. UICC's TNM Classification of Malignant Tumours, Berlin: Springer, 1987. pp. 13.
2. Allam A, Taghian A, Gioioso D, Duffy M, Suit HD. Intratumoral heterogeneity of malignant gliomas measured in vitro. Int. J. Radiat. Oncol. Biol. Phys. 1993;27:303-308.
3. Allalunis-Turner M, Day R, Pearcey R, Urtasun R. Radiosensitivity testing in gynecological tumours and malignant gliomas. In: Dewey W, Edington M, Fry R, Hall E, Whitmore G, editors. Radiation Research: A Twentieth Century Perspective, San Diego: Academic Press, 1992. pp. 712.
4. Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother. Oncol. 1994;32:1-11.
5. Bentzen SM. Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother. Oncol. 1998;46:5-18.
6. Björk-Eriksson T, West CML, Karlsson E, et al. The in vitro radiosensitivity of human head and neck cancers. Br. J. Cancer 1998;77:2371-2375.
7. Bristow R, Benchimol S, Hill R. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiother Oncol. 1996;40:197-223.
8. Bristow R, Hardy P, Hill R. Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumour cell lines I: Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels. Int. J. Radiat. Oncol. Biol. Phys. 1990;18:133-145.
9. Bristow R, Hill R. Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumour cell lines II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. Int. J. Radiat. Oncol. Biol. Phys. 1990;18:331-345.
10. Britten RA, Evans AJ, Allalunis-Turner MJ, Franko AJ, Pearcey RG. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother. Oncol. 1996;39: 145-153.
11. Brock W, Baker FL, Peters LJ. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int. J. Radit. Biol. 1989;56:751-760.
12. Brock W, Baker FL, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumour control. Int. J. Radiat. Oncol. Biol. Phys. 1990;18:1283-1286.
13. Broders A. Squamous cell epithelioma of the lip. J. Am. Med. Assoc. 1920;74:656-664.
14. Brown JM, Evans J, Kovacs MS. The prediction of human tumor radiosensitivity in situ: An approach using chromosome aberrations detected by fluorescence in situ hybridization. Int. J. Radiat. Oncol. Biol. Phys. 1992;24:279-286.
15. Davidson SE, West CML, Roberts SA, Hendry JH, Hunter RD. Radiosensitivity testing of primary cervical carcinoma: Evaluation of intra- and inter-tumour heterogeneity. Radiother. Oncol. 1990;18:349-356.
16. Deacon J, Steel GG. The responsiveness of human tumours and the initial slope of the cell survival curve. Radiother. Oncol. 1984;2:317-323.
17. Eschwege F, Bourhis J, Girinski T, et al. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: A review of the Institute Gustave Roussy experience. Int. J. Radiat. Biol. Phys. 1997;39:849-853.
18. Fertil B, Malaise E. Inherent cellular radiosensitivity as a basic concept for human tumour radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1981;7:621-629.
19. Fertil B, Malaise E. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumours: Analysis of 101 published survival curves. Int. J. Radiat. Oncol. Biol. Phys. 1985;11:1699-1707.
20. Girinski T, Bernheim A, Lubin R, et al. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: Cell characterization and correlations with local control and overall survival. Int. J. Radiat. Oncol. Biol. Phys. 1994;30:789-794.
21. Heppner G, Miller B. Therapeutic implications of tumour heterogeneity. Semin. Oncol. 1989;16:91-105.
22. Høyer M, Jørgensen KE, Bundgaard T, et al. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. Radiother. Oncol 1998;46:147-155.
23. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol. 1996;40:101-109.
24. Kocagöncü, K., Marangoni, G., Cozzi-Fogliata, A., Griffin, S., Garavaglia, G., Thum, P., Bernier, J., Cooperative Group for Predictive Tests in Radiobiology, 1994, Intrinsic radiosensitivity of head and neck carcinomas as predictive test for clinical tumour control: Comparative analysis and critical assessment of technical reliability, Radiat. Oncol. Invest., 2: 177-184.
25. Nordsmark M, Overgaard M. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 1996;41:31-39.
26. Overgaard J, Hansen H, Overgaard M, et al. A randomised double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother. Oncol. 1998;46:135-146.
27. Peters LJ. Inherent radiosensitivity of tumour and normal tissue cells as a predictor of human tumour response. Radiother. Oncol. 1990; 17:177-190.
28. Pirollo K, Hao Z, Rait A, et al. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogen 1997;14:1735-1746.
29. Ramsay J, Ward R, Bleehen N. Radiosensitivity testing of human malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 1992;24:675-680.
30. Rofstad E. Influence of cellular radiation sensitivity on local tumour control of human melanoma xenografts given fractionated radiation treatment. Cancer Res. 1991;51:4609-4612.
31. Rofstad E, Brustad T. Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo-relationship to the initial slope of the cell survival curves in vitro. Radiother. Oncol. 1987;9:45-56.
32. Selby P, Buick RN, Tannock IA. A critical appraisal of the 'human tumour stem-cell assay'. New Engl. J. Med. 1983;308:129-134.
33. Stausbøl-Grøn B, Bentzen SM, Overgaard J. Characterisation and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa. Acta Oncol. 1998;37:697-700.
34. Stausbøl-Grøn B, Bentzen SM, Jørgensen KE, Nielsen OS, Bundgaard T, Overgaard J. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: Mutual relationship and correlation with clinical data. Br. J. Cancer 1998; in press.
35. Stausbøl-Grøn B, Havsteen H, Overgaard J. Fibroblast growth in a soft agar clonogenic assay for cervix cancer radiosensitivity. Br. J. Cancer 1998;78:550-551.
36. Stausbøl-Grøn B, Nielsen OS, Bentzen SM, Overgaard J. Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay. Radiother. Oncol. 1995;37:87-99.
37. Taghian A, Ramsay J, Allalunis-Turner J, et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 1993;25:243-249.
38. Tucker S, Thames H. The effect of patient-to-patient variability on the accuracy of predictive assays of tumour response to radiotherapy: A theoretical evaluation. Int. J. Radiat. Oncol. Biol. Phys. 1989;17:145-157.
39. West CML. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br. J. Radiol. 1995;68:827-837.
40. West CML, Davidson SE, Hunter RD. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int. J. Radiat. Biol. 1989;56:761-765.
41. West CML, Davidson SE, Hunter R. Evaluation of different in vitro assays of inherent sensitivity as predictors of radiotherapy response. In: Dewey W, Edington M, Fry R, Hall E, Whitmore G, editors. Radiation Research: A Twentieth Century Perspective, San Diego: Academic Press, 1992. pp. 705.
42. West CML, Davidson SE, Roberts S, Hunter R. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 1997;76:1184-1190.
43. Whitaker SJ, Ung YC, McMillan TJ. DNA double-strand break induction and rejoining as determinants of human tumour cell radiosensitivity. A pulsed-field gel electrophoresis study. Int. J. Radiat. Biol. 1995;67:7-18.